Comparative Pharmacology
Head-to-head clinical analysis: CITANEST PLAIN DENTAL versus ORABLOC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CITANEST PLAIN DENTAL versus ORABLOC.
CITANEST PLAIN DENTAL vs ORABLOC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Propylocaine, an amide-type local anesthetic, stabilizes the neuronal membrane by binding to voltage-gated sodium channels, thereby inhibiting sodium influx and blocking conduction of nerve impulses.
Orabloc (articaine and epinephrine) is a local anesthetic that works by blocking sodium channels in neuronal membranes, preventing nerve impulse transmission. Epinephrine is a vasoconstrictor that prolongs the anesthetic effect by reducing local blood flow.
Adult dose for dental anesthesia: 20-50 mg (0.5-1.25 mL of 4% solution) by infiltration; up to 200 mg (5 mL) by nerve block. Maximum dose: 6 mg/kg, not exceeding 300 mg per appointment.
Orabloc (articaine HCl 4% with epinephrine 1:200,000): Local infiltration or nerve block. Adult: 1-7 cartridges (1.7 mL each) per procedure; max 7 mg/kg (articaine) or 500 mg (7 cartridges) per appointment.
None Documented
None Documented
Terminal elimination half-life is approximately 1.6 hours (range 1–2 hours). This short half-life allows for rapid clearance, minimizing systemic accumulation during repeated dosing in dental procedures.
Terminal elimination half-life: 2.5-3.5 hours; clinically, levels drop below therapeutic threshold within 6-8 hours.
Renal excretion of metabolites (primarily 4-hydroxyprilocaine and N-propylalanine) accounts for >95% of elimination; <5% excreted unchanged in urine. Less than 1% eliminated via feces.
Renal: 70-80% unchanged; biliary/fecal: 10-20% as metabolites.
Category C
Category C
Local Anesthetic (Dental)
Local Anesthetic (Dental)